Mr Luka Gebel
PhD Student in Strategy, International Management and Entrepreneurship
- King's Business School Advisory Council Member
Research interests
- Strategy, International Management and Entrepreneurship
Biography
Project Title: Managing Complex Innovation: Across Knowledge Domains, Product Components, and Technological Lifecycles
Supervisors: Professor Marcela Miozzo, Dr Lourdes Sosa (LSE)
Year of Entry: 2019, Full-time
Luka Gebel is a PhD candidate at King’s College London where he has also been elected on its business school advisory council. He also holds a formal appointment at the Department of Management at the London School of Economics.
Luka holds a BBA in Economics from Midwestern State University in Texas (University Valedictorian) and a MSc in Strategic Entrepreneurship and Innovation from King’s College London (Distinction, Best Dissertation Award)
His research identity concerns the inductive, mixed-method study of innovation management and technology. Under the supervision of Professor Marcela Miozzo (King's College London) and Dr Lourdes Sosa (LSE), his dissertation comprises three studies focused on managing complexity in innovation across knowledge domains, product components, and technological lifecycles.
His experience in the pharmaceutical industry drives his research and teaching in complex innovation management. Prior to his PhD, he worked at the Milner Therapeutics Institute, University of Cambridge, comprising of pharma and biotech companies such as Pfizer, AstraZeneca, BMS, and GSK, as well as a pre-seed venture arm. The institute is most known for the first CRISPR-based cancer drug trials.
Luka has taught on the MSc in Strategic Entrepreneurship and Innovation at King’s College London and Strategic Management at the London School of Economics, earning the Graduate Teaching Assistant of the Year award and a 4.7-4.9/5.0 student rating over the past three years.
Luka is also due to begin teaching at the executive programme for Advanced Leadership in Healthcare, joint between King’s and IE Business School, where he will deliver a one-day intensive course on Foresight Methodologies. His chapters in the Oxford Handbook of Pharmaceutical Medicine and his paper under review at Nature will serve as core readings for this course.
News
A management strategy for scientific breakthrough
A new study of the ‘Nobel Prize Factory’ challenges funders’ recent shift away from basic science
King's Business School appoints new members to its advisory council
Alumna and inclusion strategist Rita Kakati-Shah, McKinsey partner Louise Herring and PhD Student Luka Gebel join Advisory Council
News
A management strategy for scientific breakthrough
A new study of the ‘Nobel Prize Factory’ challenges funders’ recent shift away from basic science
King's Business School appoints new members to its advisory council
Alumna and inclusion strategist Rita Kakati-Shah, McKinsey partner Louise Herring and PhD Student Luka Gebel join Advisory Council